首页> 外国专利> ISOLATED MODIFIED CAS9 MOLECULE, METHOD TO PRODUCE A MODIFIED CAS9, PROTEIN OR RIBONUCLEOPROTEIN COMPLEXES OR COMPLEXES OF MIXED OR LIPID, COMPOSITE, LIPID, FUSION PROTEIN, NUTRITION, NUTRITION, NUTRITION IN VITRO USE OF A MODIFIED RECOMBINANT CAS9, PARTS KIT, AND, IN VITRO METHOD TO CHANGE A CELL GENOME

ISOLATED MODIFIED CAS9 MOLECULE, METHOD TO PRODUCE A MODIFIED CAS9, PROTEIN OR RIBONUCLEOPROTEIN COMPLEXES OR COMPLEXES OF MIXED OR LIPID, COMPOSITE, LIPID, FUSION PROTEIN, NUTRITION, NUTRITION, NUTRITION IN VITRO USE OF A MODIFIED RECOMBINANT CAS9, PARTS KIT, AND, IN VITRO METHOD TO CHANGE A CELL GENOME

机译:分离的改良CAS9分子,生产改良CAS9的方法,蛋白质或核糖蛋白复合物或混合或脂类,复合物,脂质,融合蛋白,营养,营养,营养的蛋白质,或在体外使用部分改良的K糖浆配制的蛋白质改变细胞基因组的体外方法

摘要

to address the limitations arising from nonspecific genomic cleavages of the cas9 of streptococcus pyogenes (spcas9) and to identify variants with greater cleavage fidelity, the present invention describes a yeast-based assay that allows the simultaneous assessment of targeted and off-target activity to two engineered genomic targets. the selection of spcas9 variants obtained by random mutagenesis of the red-ii domain allowed the identification of hits with greater reasons on the target / off target. the best performing nuclease, evocas9, was isolated by combining the mutations identified in a single variant. side-by-side analyzes with rationally designed variants previously reported demonstrated a significant improvement in the fidelity of evocas9 of the present invention.
机译:为了解决由化脓性链球菌的cas9的非特异性基因组切割引起的局限性(spcas9),并鉴定具有更高切割保真度的变体,本发明描述了基于酵母的测定法,该测定法允许同时评估针对两种的靶向和脱靶活性工程基因组靶标。通过对red-ii结构域的随机诱变获得的spcas9变体的选择,可以更有理由地鉴定靶标/非靶标的命中。通过结合单个变异体中鉴定出的突变,可以分离出性能最佳的核酸酶evocas9。与先前报道的合理设计的变体的并排分析表明,本发明的evocas9的保真度显着改善。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号